UniProt ID | MACD1_HUMAN | |
---|---|---|
UniProt AC | Q9BQ69 | |
Protein Name | O-acetyl-ADP-ribose deacetylase MACROD1 | |
Gene Name | MACROD1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 325 | |
Subcellular Localization | Nucleus . Recruited to DNA lesions, probably via mono-APD-ribosylated proteins. | |
Protein Description | Removes ADP-ribose from glutamate residues in proteins bearing a single ADP-ribose moiety. Inactive towards proteins bearing poly-ADP-ribose. Deacetylates O-acetyl-ADP ribose, a signaling molecule generated by the deacetylation of acetylated lysine residues in histones and other proteins. Plays a role in estrogen signaling. Binds to androgen receptor (AR) and amplifies the transactivation function of AR in response to androgen. May play an important role in carcinogenesis and/or progression of hormone-dependent cancers by feed-forward mechanism that activates ESR1 transactivation. Could be an ESR1 coactivator, providing a positive feedback regulatory loop for ESR1 signal transduction. Could be involved in invasive growth by down-regulating CDH1 in endometrial cancer cells. Enhances ESR1-mediated transcription activity.. | |
Protein Sequence | MSLQSRLSGRLAQLRAAGQLLVPPRPRPGHLAGATRTRSSTCGPPAFLGVFGRRARTSAGVGAWGAAAVGRTAGVRTWAPLAMAAKVDLSTSTDWKEAKSFLKGLSDKQREEHYFCKDFVRLKKIPTWKEMAKGVAVKVEEPRYKKDKQLNEKISLLRSDITKLEVDAIVNAANSSLLGGGGVDGCIHRAAGPLLTDECRTLQSCKTGKAKITGGYRLPAKYVIHTVGPIAYGEPSASQAAELRSCYLSSLDLLLEHRLRSVAFPCISTGVFGYPCEAAAEIVLATLREWLEQHKDKVDRLIICVFLEKDEDIYRSRLPHYFPVA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
90 | Phosphorylation | MAAKVDLSTSTDWKE HEECCCCCCCCCHHH | 18.82 | 20873877 | |
91 | Phosphorylation | AAKVDLSTSTDWKEA EECCCCCCCCCHHHH | 42.83 | 20873877 | |
92 | Phosphorylation | AKVDLSTSTDWKEAK ECCCCCCCCCHHHHH | 22.46 | 25627689 | |
93 | Phosphorylation | KVDLSTSTDWKEAKS CCCCCCCCCHHHHHH | 46.06 | 20873877 | |
96 | Ubiquitination | LSTSTDWKEAKSFLK CCCCCCHHHHHHHHH | 51.08 | - | |
96 | Succinylation | LSTSTDWKEAKSFLK CCCCCCHHHHHHHHH | 51.08 | 23954790 | |
96 | Acetylation | LSTSTDWKEAKSFLK CCCCCCHHHHHHHHH | 51.08 | 25953088 | |
96 | Succinylation | LSTSTDWKEAKSFLK CCCCCCHHHHHHHHH | 51.08 | - | |
100 | Phosphorylation | TDWKEAKSFLKGLSD CCHHHHHHHHHCCCH | 42.74 | 24719451 | |
103 | Malonylation | KEAKSFLKGLSDKQR HHHHHHHHCCCHHHH | 56.65 | 26320211 | |
103 | Acetylation | KEAKSFLKGLSDKQR HHHHHHHHCCCHHHH | 56.65 | 19608861 | |
103 | Succinylation | KEAKSFLKGLSDKQR HHHHHHHHCCCHHHH | 56.65 | - | |
103 | Succinylation | KEAKSFLKGLSDKQR HHHHHHHHCCCHHHH | 56.65 | - | |
117 | Malonylation | REEHYFCKDFVRLKK HHHHHCCCHHHHHHC | 44.28 | 32601280 | |
129 | Succinylation | LKKIPTWKEMAKGVA HHCCCCHHHHHCCCE | 39.84 | - | |
129 | Malonylation | LKKIPTWKEMAKGVA HHCCCCHHHHHCCCE | 39.84 | 26320211 | |
129 | Succinylation | LKKIPTWKEMAKGVA HHCCCCHHHHHCCCE | 39.84 | - | |
129 | Acetylation | LKKIPTWKEMAKGVA HHCCCCHHHHHCCCE | 39.84 | 26822725 | |
133 | Succinylation | PTWKEMAKGVAVKVE CCHHHHHCCCEEEEC | 53.24 | 23954790 | |
138 | Sumoylation | MAKGVAVKVEEPRYK HHCCCEEEECCCCHH | 33.90 | 28112733 | |
138 | Sumoylation | MAKGVAVKVEEPRYK HHCCCEEEECCCCHH | 33.90 | - | |
148 | Acetylation | EPRYKKDKQLNEKIS CCCHHHHHHHHHHHH | 66.61 | 25953088 | |
153 | Acetylation | KDKQLNEKISLLRSD HHHHHHHHHHHHHHC | 36.20 | 25953088 | |
163 | Acetylation | LLRSDITKLEVDAIV HHHHCCHHHHHHHHH | 42.88 | 23236377 | |
206 | 2-Hydroxyisobutyrylation | CRTLQSCKTGKAKIT CCHHHHCCCCCCEEC | 66.61 | - | |
222 | Phosphorylation | GYRLPAKYVIHTVGP CCCCCCEEEEEECCC | 13.52 | 26437602 | |
226 | Phosphorylation | PAKYVIHTVGPIAYG CCEEEEEECCCHHCC | 18.94 | 22673903 | |
232 | Phosphorylation | HTVGPIAYGEPSASQ EECCCHHCCCCCHHH | 23.81 | 27642862 | |
236 | Phosphorylation | PIAYGEPSASQAAEL CHHCCCCCHHHHHHH | 35.93 | 28348404 | |
238 | Phosphorylation | AYGEPSASQAAELRS HCCCCCHHHHHHHHH | 25.37 | 28348404 | |
244 | Methylation | ASQAAELRSCYLSSL HHHHHHHHHHHHHHH | 19.04 | 115482467 | |
297 | Acetylation | WLEQHKDKVDRLIIC HHHHCCHHCCEEEEE | 51.33 | 25953088 | |
309 | Acetylation | IICVFLEKDEDIYRS EEEEEECCCHHHHHH | 69.44 | 30590221 | |
321 | Phosphorylation | YRSRLPHYFPVA--- HHHCCCCCCCCC--- | 13.98 | 27642862 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MACD1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MACD1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MACD1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NEMO_HUMAN | IKBKG | physical | 25735744 | |
PARP1_HUMAN | PARP1 | physical | 25735744 | |
XRCC6_HUMAN | XRCC6 | physical | 25735744 | |
XRCC5_HUMAN | XRCC5 | physical | 25735744 | |
IKKB_HUMAN | IKBKB | physical | 25735744 | |
RB6I2_HUMAN | ERC1 | physical | 25735744 | |
E2AK2_HUMAN | EIF2AK2 | physical | 25735744 | |
HNRPU_HUMAN | HNRNPU | physical | 25735744 | |
CSTF3_HUMAN | CSTF3 | physical | 25735744 | |
YBOX1_HUMAN | YBX1 | physical | 25735744 | |
DHX9_HUMAN | DHX9 | physical | 25735744 | |
DDX21_HUMAN | DDX21 | physical | 25735744 | |
2AAA_HUMAN | PPP2R1A | physical | 25735744 | |
H2AX_HUMAN | H2AFX | physical | 28514442 | |
PARP1_HUMAN | PARP1 | physical | 28514442 | |
PARP2_HUMAN | PARP2 | physical | 28514442 | |
SP16H_HUMAN | SUPT16H | physical | 28514442 | |
XPC_HUMAN | XPC | physical | 28514442 | |
SSRP1_HUMAN | SSRP1 | physical | 28514442 | |
CETN2_HUMAN | CETN2 | physical | 28514442 | |
DNLI3_HUMAN | LIG3 | physical | 28514442 | |
HBE_HUMAN | HBE1 | physical | 28514442 | |
RFA1_HUMAN | RPA1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-103, AND MASS SPECTROMETRY. |